Vijaya Diagnostics on February 5 reported a 58 percent year-on-year rise in consolidated net profit at Rs 25.8 crore for the December quarter of the current financial year.
The company reported a net profit of Rs 16.4 crore in the same period a year ago.
The revenue of the company, whose operations predominantly relate to providing diagnostic services in pathology services, came in at Rs 132.7 crore, up 17.3 percent from last year's Rs 113.1 crore.
Earnings before interest, taxes, depreciation and amortisation (EBITDA) were at Rs 52.3 crore. The EBITDA margin was at 39.4 percent against 39.1 percent in the year-ago period.
“Marking entry into the state of Karnataka, we inaugurated a futuristic hub at Gulbarga in Nov 2023. Market response and business performance has been encouraging. We believe that we will be able to break even within anticipated timelines and are confident about sufficiently addressing market need and effective expansion in the region (Karnataka),” said Suprita Reddy, MD & CEO in a press statement.
Vijaya Diagnostics' non-Covid revenue growth was essentially volume driven. Furthermore, the uptrend both in radiology and pathology segments reinforces the effectiveness of integrated business model. The quarter’s non-Covid business comprised 99.8 percent of revenue from operations as against 99.2 percent in Q3FY23. Revenue contribution from B2C segment stood at 94 percent in the quarter.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
